| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/04/1996 | CA2199009A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704448A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/03/1996 | EP0704434A1 6-Amino-1,4-dihydropyridines and their use as selective k-channel modulators |
| 04/03/1996 | EP0704219A2 A novel osteoblastic proliferative factor |
| 04/03/1996 | EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0703917A1 Indolocarbazole compound useful as proteinkinase c inhibitor |
| 04/03/1996 | EP0703908A1 Analgesic dibenzoxazepines and dibenzothiazepines |
| 04/03/1996 | EP0703905A1 Inhibitors of farnesyl-protein transferase |
| 04/03/1996 | EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0703787A1 Cell growth regulators |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0703780A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/03/1996 | EP0539503B1 Excitatory amino acid antagonists |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | EP0490891B1 Drug containing matrix |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/03/1996 | CN1119866A Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno|2,3-b¨thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/03/1996 | CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 04/03/1996 | CN1119529A Method of promoting hair growth |
| 04/02/1996 | US5504213 Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives |
| 04/02/1996 | US5504212 Inhibitors of farnesyl-protein transferase |
| 04/02/1996 | US5504205 Reduced sp3 texaphyrins |
| 04/02/1996 | US5504115 Inhibitors of farnesyl protein transferase |
| 04/02/1996 | US5504108 Optically pure 4-aryl-2-hydroxytetronic acids |
| 04/02/1996 | US5504107 Anticoagulants, preventing atherosclerosis |
| 04/02/1996 | US5504103 Contacting cells with antitumor agents |
| 04/02/1996 | US5504094 Use of bengothiophenls to treat pain due to an excess of neuropeptide y |
| 04/02/1996 | US5504088 Acetylcholine esterase inhibitors; alzheimer's disease and other diseases caused by a low concentration of choline |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5504074 Administering substituted estranes to suppress vascularization |
| 04/02/1996 | US5503831 Foodstuff; obesity treatment |
| 04/02/1996 | US5503828 Alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/30/1996 | CA2159425A1 New heterocycle substituted imidazolidines; process and intermediates for preparing them and their use as drugs; pharmaceutical compositions containing the same |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009382A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996009373A1 Fibroblasts for the treatment of muscular disorders |
| 03/28/1996 | WO1996009317A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009310A1 Derivatives of carbohydrates and compositions containing them |
| 03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
| 03/28/1996 | WO1996009302A1 Bicyclic carboxamides as 5-ht1a antagonists |
| 03/28/1996 | WO1996009294A1 Substituted heteroaromatic compounds and their use in medicine |
| 03/28/1996 | WO1996009288A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 03/28/1996 | WO1996009287A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
| 03/28/1996 | WO1996009045A1 Antiestrogenic benzothiophenyl compounds |
| 03/28/1996 | WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/28/1996 | CA2200722A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 03/28/1996 | CA2200472A1 Novel heterocyclic derivatives, method of prodution thereof and pharmaceutical use thereof |
| 03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | CA2200443A1 Bicyclic carboxamides as 5-ht1a antagonists |
| 03/28/1996 | CA2200354A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | CA2198379A1 Fibroblasts for the treatment of muscular disorders |
| 03/27/1996 | EP0703239A1 Aminomethylphosphonic and aminomethylphosphinic acids derivatives and their use in the treatment of degenerative articular diseases |
| 03/27/1996 | EP0703232A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors |
| 03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
| 03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
| 03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
| 03/27/1996 | EP0703218A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 03/27/1996 | EP0702954A2 Calcium dietary supplement |
| 03/27/1996 | EP0702951A1 Use of a NO-synthetase inhibitor as medicament for reducing alcohol consumption or for preventing excessive alcohol consumption |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702680A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives |
| 03/27/1996 | EP0702678A1 Aniline derivatives |
| 03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/27/1996 | EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/27/1996 | EP0702554A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 03/27/1996 | EP0646005A4 Methods for treating arteriosclerosis. |
| 03/27/1996 | EP0608404B1 ANDROST-4-ENO[4,5-b]PYRROLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 03/27/1996 | EP0473687B1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester |
| 03/27/1996 | CN1119457A Bone stimulating factor |
| 03/27/1996 | CN1119434A Phenoxyphenylacetic acid derivatives |
| 03/27/1996 | CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them |
| 03/27/1996 | CN1119187A oxalylamino-benzofuran- and benzothienyl-derivatives |
| 03/27/1996 | CN1119121A Crystalline interleukin-4 |
| 03/27/1996 | CN1119101A Thieno (1,5) benzodiazepine use |
| 03/27/1996 | CN1031404C Process for production of substituted azole |
| 03/27/1996 | CN1031403C Process for preparation of hydroxyalkylfuranyl derivatives |
| 03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
| 03/27/1996 | CA2158811A1 Calcium dietary supplement |
| 03/26/1996 | US5502198 α-aryl or heteroaryl-substituted amide ester ACAT inhibitors |
| 03/26/1996 | US5502074 Benzothiophenes for bone healing and fracture repair |
| 03/26/1996 | US5502072 Substituted oxindoles |
| 03/26/1996 | US5502066 Inhibitors of tumor necrosis factors |
| 03/26/1996 | US5502060 HIV protease inhibitors |
| 03/26/1996 | US5502059 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them |
| 03/26/1996 | US5502058 Lidocaine and dextromethorphan or dextrophan |